XBP (XBP Global Holdings, Inc. Common Stock) Stock Analysis - SEC Filings

XBP Global Holdings, Inc. Common Stock (XBP) is a publicly traded Technology sector company. As of May 21, 2026, XBP trades at $2.41 with a market cap of $24.30M and a P/E ratio of 0.00. XBP moved -0.20% today. Year to date, XBP is -67.30%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.00 to $25.60. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces XBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find XBP SEC filings?

Rallies organizes XBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

XBP Key Metrics

Key financial metrics for XBP
MetricValue
Price$2.41
Market Cap$24.30M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$25.60
52-Week Low$2.00
Volume0
Avg Volume0
Revenue (TTM)$791.04M
Net Income$1.10B
Gross Margin21.70%

Latest XBP News

Recent XBP Insider Trades

  • Klein Randal T bought 25.00K (~$61.10K) on May 19, 2026.
  • Klein Randal T bought 150.00K (~$80.33K) on Aug 18, 2025.
  • CFAC Holdings VIII, LLC. sold 23.16K (~$245.49K) on Dec 14, 2023.

XBP Analyst Consensus

1 analysts cover XBP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.

Common questions about XBP

Where can I find XBP SEC filings?
Rallies organizes XBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show XBP 10-K and 10-Q filings?
Rallies organizes XBP SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is XBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XBP. It does not provide personalized investment advice.
XBP

XBP